Evidence behind this recommendation.
Selected studies from our library that inform the recommendations on this page. Evidence grade shown when available.
Acupuncture for treating fibromyalgia (Cochrane Review)
“Cochrane systematic review by Deare et al. analyzed 9 randomized controlled trials (395 patients). Electroacupuncture demonstrated moderate evidence of superiority over sham acupuncture in reducing pain, stiffness, and improving global well-being in fibromyalgia, with effects sustained for up to 6 months.”
Effectiveness of acupuncture in fibromyalgia: a pragmatic randomized trial
“Pragmatic randomized trial with 100 patients demonstrated that acupuncture significantly reduced pain scores on the Fibromyalgia Impact Questionnaire (FIQ), with a mean improvement of 41% in the total score compared with 27% in the control group after 12 weeks of treatment.”
What Is Fibromyalgia?
Fibromyalgia is a chronic widespread pain syndrome characterized by diffuse musculoskeletal pain, profound fatigue, sleep disturbances, and painful hypersensitivity at multiple body sites. Unlike conditions with identifiable tissue injury, fibromyalgia is a disease of central sensitization — the central nervous system amplifies pain signals, processing normal stimuli as pain.
The American College of Rheumatology diagnostic criteria (ACR 2010/2016) define fibromyalgia by the presence of widespread pain (Widespread Pain Index ≥ 7 and Symptom Severity Scale ≥ 5, or pain index 4-6 with symptom severity scale ≥ 9), with symptoms present for at least 3 months and no other condition that fully explains the pain.
Medical acupuncture, especially low-frequency electroacupuncture (2 Hz), acts directly on the central mechanisms of fibromyalgia: it modulates sensitization of the spinal cord dorsal horn, restores sleep architecture, and promotes the release of endogenous opioids — addressing the pathophysiology of the disease, not only the symptoms.
FIBROMYALGIA IN NUMBERS
Central Sensitization
The brain and spinal cord amplify pain signals — stimuli that should not cause pain are perceived as painful (allodynia).
Non-Restorative Sleep
Reduction of deep sleep (stage N3) perpetuates pain: without restorative sleep, there is no muscle restoration nor adequate pain modulation.
Altered Neurotransmitters
Elevated levels of substance P in cerebrospinal fluid and reduced serotonin and norepinephrine — an imbalance that amplifies pain and impairs sleep.
Central Sensitization and Diffuse Pain: The Mechanism of Fibromyalgia
In fibromyalgia, the central nervous system operates in a state of permanent hyperexcitability. Neurons in the spinal cord dorsal horn show reduced activation thresholds and expanded receptive fields — a phenomenon called wind-up. This means that mild mechanical stimuli (normal pressure on muscles) are amplified and interpreted as intense pain.
This state of central sensitization is sustained by measurable neurochemical alterations: substance P (a pro-nociceptive neurotransmitter) is elevated up to 3-fold in the cerebrospinal fluid of patients with fibromyalgia, while serum serotonin and norepinephrine — neurotransmitters that normally inhibit pain in descending pathways — are significantly reduced.
This imbalance creates a vicious cycle: excess nociceptive facilitation (elevated substance P) and a deficit of descending inhibition (low serotonin and norepinephrine). The pain becomes independent of peripheral injury — the central nervous system generates and maintains the pain on its own.
Pathophysiological Cycle of Fibromyalgia
Sensitization of the Dorsal Horn
Second-order neurons in the spinal cord become hyperexcitable. Activation thresholds drop and receptive fields expand — the wind-up phenomenon that amplifies any peripheral stimulus.
Neurochemical Imbalance
Elevated substance P (3× normal in CSF) facilitates pain transmission. Reduced serotonin and norepinephrine weaken the descending PAG-RVM inhibitory pathway, leaving the system "without brakes".
Deep Sleep Dysfunction
Intrusion of alpha waves into delta sleep (stage N3) prevents restorative sleep. Without nighttime restoration, there is an increase in pro-inflammatory cytokines and a reduction of the pain threshold the following day.
Diffuse Pain and Fatigue
Allodynia (pain to normal stimuli) and hyperalgesia (increased pain to painful stimuli) become generalized. Profound fatigue results from non-restorative sleep and chronic activation of the alarm system.
Chronification and Comorbidities
The cycle is self-perpetuating: pain worsens sleep, poor sleep intensifies pain. Comorbidities arise: depression, anxiety, irritable bowel syndrome, chronic tension-type headache.
Why Pharmacological Treatments Are Not Always Sufficient?
Standard pharmacological treatment of fibromyalgia uses three main classes: anticonvulsants (pregabalin), dual antidepressants (duloxetine, milnacipran), and analgesics. Although approved by regulatory agencies, these medications have significant limitations in clinical practice.
Pregabalin, the most studied drug, reduces pain in only 30-50% of treated patients, with clinically significant improvement (>30% reduction on the pain scale) in about 40% of cases. Side effects such as weight gain, drowsiness, and peripheral edema limit adherence: up to 30% of patients discontinue treatment due to intolerance.
Duloxetine improves pain and mood simultaneously, but causes nausea in up to 30% of patients and may provoke a discontinuation syndrome when stopped. None of these drugs adequately restore deep sleep (stage N3) — an essential component of fibromyalgia.
PHARMACOLOGICAL TREATMENT VS. ELECTROACUPUNCTURE IN FIBROMYALGIA
| ASPECT | PREGABALIN / DULOXETINE | ELECTROACUPUNCTURE 2 HZ |
|---|---|---|
| Mechanism on pain | Modulation of calcium channels / serotonin-norepinephrine reuptake | Release of β-endorphins and enkephalins + descending PAG-RVM modulation |
| Response rate | 30-50% with significant improvement | 50-70% with significant improvement (Cochrane 2013) |
| Effect on sleep | Limited (pregabalin improves latency, not architecture) | Restores deep N3 sleep via serotonergic modulation |
| Side effects | Weight gain, drowsiness, nausea, edema, discontinuation | Generally mild (hematoma, transient local pain, vasovagal syncope); serious events such as pneumothorax and infection are rare but described |
| Long-term use | Possible tolerance, dependence (pregabalin), discontinuation | Safe and sustainable — no demonstrated tolerance |
| Comorbidities | Duloxetine helps depression; pregabalin may worsen mood | Improves pain, sleep, fatigue, and mood simultaneously |
How Does Medical Acupuncture Work in Fibromyalgia?
Medical acupuncture for fibromyalgia acts on three simultaneous targets: reduction of central sensitization (dorsal horn and brain), restoration of sleep architecture (increase of deep N3 sleep), and release of endogenous opioids (β-endorphins, enkephalins). The modality with the strongest evidence for fibromyalgia is low-frequency electroacupuncture (2 Hz).
Electrical stimulation at 2 Hz preferentially activates type II and III afferent fibers, which project to the spinal cord dorsal horn and, by ascending pathways, to the periaqueductal gray (PAG) and the nucleus raphe magnus (NRM). This activation triggers the release of β-endorphins in the cerebrospinal fluid and enkephalins at segmental synapses — a potent endogenous analgesic system that reduces neuronal hyperexcitability without the side effects of medications.
Mechanisms of Electroacupuncture 2 Hz in Fibromyalgia
Activation of Afferent Fibers (Type II/III)
Electroacupuncture at 2 Hz stimulates muscle afferent fibers that project to the spinal cord and brainstem, activating pain-modulation circuits that are hypoactive in fibromyalgia.
Release of β-Endorphins and Enkephalins
The 2 Hz frequency maximizes the release of β-endorphins (suprasegmental) and met-enkephalins (segmental). These endogenous opioids reduce hyperexcitability of dorsal horn neurons — the epicenter of central sensitization.
Activation of the Descending Inhibitory Pathway (PAG-RVM)
The periaqueductal gray → nucleus raphe magnus → dorsal horn axis is reactivated: serotonin and norepinephrine are released at spinal inhibitory synapses, restoring the "brake" that is deficient in fibromyalgia.
Modulation of Substance P and CGRP
Electroacupuncture reduces substance P and CGRP levels in the dorsal horn, decreasing the excessive nociceptive facilitation that characterizes central sensitization in fibromyalgia.
Restoration of Deep Sleep (N3)
The serotonergic modulation induced by electroacupuncture improves sleep architecture: increased time in stage N3, reduced alpha-delta intrusion, and improved restorative sleep — breaking the pain-insomnia-pain cycle.
Scientific Evidence
Acupuncture for fibromyalgia has growing evidence in systematic reviews and meta-analyses. The 2013 Cochrane Review (Deare et al.) is the most cited reference, but subsequent studies reinforce the findings. Electroacupuncture consistently emerges as the most effective modality — superior to manual acupuncture and sham acupuncture.
CLINICAL OUTCOMES IN CONTROLLED TRIALS
EVIDENCE BY ACUPUNCTURE MODALITY IN FIBROMYALGIA
| MODALITY | LEVEL OF EVIDENCE | MAIN FINDINGS |
|---|---|---|
| Electroacupuncture 2 Hz | Moderate (Cochrane 2013) | Superior to sham for pain, stiffness, and global well-being; effects sustained for up to 6 months |
| Manual acupuncture | Low (Cochrane 2013) | Subjective improvement, but no statistical superiority over sham in most outcomes |
| Acupuncture + medication | Moderate (meta-analyses) | Combination of acupuncture with pregabalin or duloxetine superior to medication alone in pain and sleep |
| Auricular acupuncture | Low-moderate | Preliminary evidence of benefit on sleep and anxiety; more high-quality trials needed |
When to See a Medical Acupuncturist
Fibromyalgia responds to medical acupuncture especially when pharmacological treatment alone is insufficient or when side effects limit adherence. The medical acupuncturist evaluates the case individually and integrates electroacupuncture into the therapeutic plan, coordinating with the rheumatologist or pain physician when necessary.
Profiles With the Best Response to Electroacupuncture
- Chronic diffuse pain (more than 3 months) that meets ACR criteria for fibromyalgia
- Partial response or intolerance to pregabalin, duloxetine, or milnacipran
- Non-restorative sleep as the predominant complaint — improvement in sleep is usually the first response perceived
- Fibromyalgia with comorbid chronic tension-type headache or irritable bowel syndrome
- Patients who wish to reduce the dose of medications under medical supervision
- Fibromyalgia secondary to chronic untreated myofascial trigger points
Frequently Asked Questions
Frequently Asked Questions
The recommended initial series is 8-12 sessions of electroacupuncture, with response assessment at week 4. Most responder patients notice sleep improvement in the first 2-3 weeks and progressive pain reduction starting at week 4. After the initial series, monthly maintenance sessions help sustain the benefit.
Medical acupuncture is often used as a complementary treatment, not a substitute. Many patients manage to reduce the dose of pregabalin or duloxetine during the course of electroacupuncture sessions, but this reduction must always be gradual and under the supervision of the prescribing physician. Some patients with mild to moderate fibromyalgia achieve adequate control with electroacupuncture as the main treatment.
Yes, they are distinct approaches. In fibromyalgia, the target is central sensitization — we use electroacupuncture at 2 Hz to release endogenous opioids and modulate descending pain pathways. In myofascial pain syndrome, the target is the peripheral trigger point — we use dry needling directly into the muscle nodule. When fibromyalgia and trigger points coexist, we combine both approaches in the same session.
Yes. Electroacupuncture has a good safety profile when performed by a qualified medical acupuncturist. The most common adverse effects are mild (hematoma at the puncture site, transient pain, vasovagal syncope); serious events such as pneumothorax and infection are rare but described in the literature. Absolute contraindications include patients with cardiac pacemakers and uncontrolled epilepsy. Patients with fibromyalgia often have hypersensitivity — the physician adjusts the intensity of electrical stimulation individually.
Central sensitization is the state in which the central nervous system (spinal cord and brain) amplifies pain signals, processing normal stimuli as painful (allodynia) and painful stimuli as much more intense (hyperalgesia). In fibromyalgia, this phenomenon is the central mechanism of the disease — and that is why treatments that act only on the periphery (anti-inflammatories, for example) are insufficient. Electroacupuncture acts directly on the altered central circuits.
Fibromyalgia is a chronic condition that currently has no definitive cure, but it can be effectively controlled with adequate treatment. Medical acupuncture does not cure fibromyalgia, but it is an important tool in symptom control: it reduces diffuse pain, improves sleep, decreases fatigue, and may allow medication reduction. The goal of treatment is to restore the patient's functionality and quality of life.